These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14551009)

  • 21. Universal Repeat Screening for Human Immunodeficiency Virus in the Third Trimester of Pregnancy: A Cost-Effectiveness Analysis.
    Hawkinson LF; Chaiken SR; Doshi U; Wallace J; Caughey AB
    Obstet Gynecol; 2023 Mar; 141(3):535-543. PubMed ID: 36800852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy.
    Myers ER; Thompson JW; Simpson K
    Obstet Gynecol; 1998 Feb; 91(2):174-81. PubMed ID: 9469271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost effectiveness of voluntary prenatal and routine newborn HIV screening in the United States.
    Zaric GS; Bayoumi AM; Brandeau ML; Owens DK
    J Acquir Immune Defic Syndr; 2000 Dec; 25(5):403-16. PubMed ID: 11141240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of integrated routine offering of prenatal HIV and syphilis screening in China.
    Owusu-Edusei K; Tao G; Gift TL; Wang A; Wang L; Tun Y; Wei X; Wang L; Fuller S; Kamb ML; Bulterys M
    Sex Transm Dis; 2014 Feb; 41(2):103-10. PubMed ID: 24413489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of HIV screening for incarcerated pregnant women.
    Resch S; Altice FL; Paltiel AD
    J Acquir Immune Defic Syndr; 2005 Feb; 38(2):163-73. PubMed ID: 15671801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of a repeat HIV test in pregnancy in India.
    Joshi S; Kulkarni V; Gangakhedkar R; Mahajan U; Sharma S; Shirole D; Chandhiok N
    BMJ Open; 2015 Jun; 5(6):e006718. PubMed ID: 26068507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of repeat HIV testing during pregnancy in southwestern Kenya: progress and missed opportunities.
    Rogers AJ; Akama E; Weke E; Blackburn J; Owino G; Bukusi EA; Oyaro P; Kwena ZA; Cohen CR; Turan JM
    J Int AIDS Soc; 2017 Dec; 20(4):. PubMed ID: 29236362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Universal HIV screening of pregnant women in England: cost effectiveness analysis.
    Postma MJ; Beck EJ; Mandalia S; Sherr L; Walters MD; Houweling H; Jager JC
    BMJ; 1999 Jun; 318(7199):1656-60. PubMed ID: 10373167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Voluntary screening program for HIV in pregnancy. Cost effectiveness.
    Rivera-Alsina ME; Rivera CC; Rollene N; Kirby RS; Ayres A; McNamara M
    J Reprod Med; 2001 Mar; 46(3):243-8. PubMed ID: 11304866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative analysis of costs of single and dual rapid HIV and syphilis diagnostics: results from a randomised controlled trial in Colombia.
    Obure CD; Gaitan-Duarte H; Losada Saenz R; Gonzalez L; Angel-Muller E; Laverty M; Perez F
    Sex Transm Infect; 2017 Nov; 93(7):482-486. PubMed ID: 28495681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.
    Paltiel AD; Walensky RP; Schackman BR; Seage GR; Mercincavage LM; Weinstein MC; Freedberg KA
    Ann Intern Med; 2006 Dec; 145(11):797-806. PubMed ID: 17146064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness analysis of Option B+ for HIV prevention and treatment of mothers and children in Malawi.
    Fasawe O; Avila C; Shaffer N; Schouten E; Chimbwandira F; Hoos D; Nakakeeto O; De Lay P
    PLoS One; 2013; 8(3):e57778. PubMed ID: 23554867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACOG Committee Opinion No. 752 Summary: Prenatal and Perinatal Human Immunodeficiency Virus Testing.
    Obstet Gynecol; 2018 Sep; 132(3):805-806. PubMed ID: 30134421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis.
    Plunkett BA; Grobman WA
    Am J Obstet Gynecol; 2005 Apr; 192(4):1153-61. PubMed ID: 15846195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmaco-economic evaluation of mandatory HIV-screening in pregnancy; a cost-efficacy analysis in Amsterdam].
    Postma MJ; van den Hoek JA; Beck EJ; Heeg B; Jager JC; Coutinho RA
    Ned Tijdschr Geneeskd; 2000 Apr; 144(16):749-54. PubMed ID: 10812443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Third-Trimester Prenatal Syphilis Screening: A Cost-Effectiveness Analysis.
    Albright CM; Emerson JB; Werner EF; Hughes BL
    Obstet Gynecol; 2015 Sep; 126(3):479-485. PubMed ID: 26244531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV Screening During Pregnancy in a U.S. HIV Epicenter.
    Szlachta-McGinn A; Aserlind A; Duthely L; Oldak S; Babriwala R; Montgomerie E; Potter J
    Infect Dis Obstet Gynecol; 2020; 2020():8196342. PubMed ID: 32454582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perinatally human immunodeficiency virus-1 infected children born to low risk mothers who tested antibody negative during pregnancy: three cases.
    Wallihan R; Koranyi K; Brady M
    Pediatr Infect Dis J; 2010 Mar; 29(3):274-5. PubMed ID: 19935119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.